MicroPort CardioFlow Medtech (HKG:2160) said it entered distribution agreements with its substantial shareholder MicroPort, according to a Hong Kong bourse filing Wednesday.
Shares of the medical device company were 3% lower in morning trade Thursday.
Under the agreements, MicroPort CardioFlow received non-exclusive rights to distribute certain products overseas.
The distribution frameworks will last until Dec. 31, 2028, the firm said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.